Gregor is a Lead Translational Computational Biologist and is responsible for the evaluation and prioritisation of drug targets leveraging in-house tools. Gregor holds a PhD in cancer and chemical biology from the Francis Crick Institute and Imperial College London. Prior to joining CoSyne, Gregor worked at different companies in the pharmaceutical and biotech industry at the interface of multi-modal biomedical data and the translation of data-driven insights from lab to bedside. Generally, he enjoys working in multi-disciplinary teams with broad, diverse backgrounds tackling complex problems.